| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |